Elion Therapeutics, a biotech focused on invasive fungal infections, has raised $81 million in a Series B funding round for its early-stage candidate, it announced …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A convicted felon who hopscotched his way into high-paying health executive positions all over the country despite a federal prison term has once again landed
The Food and Drug Administration’s rare pediatric disease priority review voucher program, which has been providing incentives for lifesaving innovations since 2012, is doomed to
A new paper explores how PMDs affect the time of menopause and the severity of vasomotor menopausal symptoms like hot flashes.